Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C InfectionMartin R. Jakobsen, Paul R. Gorry, Maëlenn Gouillou et al.|PLoS ONE|2013Cited by 48
Quantifying Susceptibility of CD4+ Stem Memory T-Cells to Infection by Laboratory Adapted and Clinical HIV-1 StrainsJacqueline K. Flynn, Paul R. Gorry, Geza Paukovics et al.|Viruses|2014Cited by 31
Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitrousage of alternative coreceptors during progressive HIV-1 subtype C infectionKieran Cashin, Paul R. Gorry, Martin R. Jakobsen et al.|Retrovirology|2013Cited by 22
Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maravirocKatharina Borm, Paul R. Gorry, Martin R. Jakobsen et al.|Retrovirology|2016Cited by 5